Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers
Protocol ID
LOXO-EXT-17005
Disease (Sub Disease)
Solid tumours
Diagnosis Stage
Relapse/ refractory
Sponsor
Bayer
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
1 Month and older
International registry ID's
NCT03215511
| Study Title | A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers |
|---|---|
| Protocol ID | LOXO-EXT-17005 |
| Disease (Sub Disease) | Solid tumours |
| Diagnosis Stage | Relapse/ refractory |
| Sponsor | Bayer |
| Links | https://clinicaltrials.gov/ct2/show/NCT03215511 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 11/07/2018 |
| Study Type | Treatment |
| Phase | Phase 1/2 |
| Age Eligibility | 1 Month and older |
| International registry ID's | NCT03215511 |